Related Experiment Video
Updated: Jun 14, 2025

Production and Detection of Reactive Oxygen Species ROS in Cancers
Published on: November 21, 2011
The Role of Redox Environment in Tumors
Jiaping Wu1, Liling Hu2, Wei Liu2
1Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Science, China Three Gorges University, Yichang, 443002, China.
Reactive Oxygen Species (ROS) and the redoxin system control the cellular redox environment, impacting tumor growth and development. Targeting these redox pathways offers a promising strategy for improving cancer therapy outcomes.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Reactive Oxygen Species (ROS) and the redoxin system are key regulators of the cellular redox environment.
- The redox balance is crucial for physiological processes and is implicated in tumor occurrence and development.
- Dysregulation of redox signaling pathways affects tumor cell proliferation, migration, invasion, and cell death.
Purpose of the Study:
- To elucidate the mechanisms of redox environment regulation in cancer.
- To introduce redox-sensitive transcription factors and their downstream signaling pathways.
- To review the therapeutic applications of inhibitors targeting these transcription factors in tumor treatment.
Main Methods:
- Literature review of studies on redox biology and cancer.
- Analysis of redox-sensitive transcription factors and their signaling cascades.
- Examination of therapeutic strategies involving targeted inhibitors.
Main Results:
- Redox-sensitive transcription factors play a significant role in mediating tumor progression.
- Specific signaling pathways activated by these factors contribute to cancer hallmarks.
- Inhibitors targeting these factors show potential in preclinical and clinical settings.
Conclusions:
- Understanding redox environment regulation is essential for effective cancer therapy.
- Targeting redox-sensitive transcription factors presents a viable therapeutic avenue.
- Further research into these pathways can lead to novel anti-cancer treatments.
More Related Videos
10:46In Vivo EPR Assessment of pH, pO2, Redox Status, and Concentrations of Phosphate and Glutathione in the Tumor Microenvironment
Published on: March 16, 2018
09:44Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia
Published on: September 5, 2019
Related Concept Videos
The Tumor Microenvironment
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Redox Equilibria: Overview
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...